Generation of Immortalized Equine Chondrocytes With Inducible Sox9 Expression Allows Control of Hypertrophic Differentiation.

The research article focuses on creating immortalized equine chondrocyte cell lines that can control hypersensitive responses, thereby maintaining long-term in-vitro culture stages. The study uses SV40 large T antigen and human telomerase reverse transcriptase to achieve the desired results.

The Immortalization of Chondrocytes

• In this study, the researchers used SV40 large T antigen and human telomerase reverse transcriptase to immortalize pooled equine chondrocytes through lentiviral vector mediated transduction either singly or in combination.
• These transformed chondrocytes were able to proliferate stably over multiple passages. However, it resulted in considerably lower expression of specific collagen II mRNA and up-regulation of hypertrophied marker collagen X in three-dimensional cultures.

Construction of GFP Reporter for Monitoring

• To monitor chondrogenic differentiation in real-time, the researchers constructed a Col2a1 promoter-driven GFP reporter.
• They observed a significant increase in promoter activation when the cell cultures were treated with the growth factor TGFβ-3.

Recapitulation of Native Articular Chondrocyte Phenotype

• The researchers further transduced large T antigen-immortalized chondrocytes with lentiviral vectors.
• These allowed for either regular or doxycycline-induced expression of Sox9, the protein that regulates chondrocyte differentiation and cartilage formation.
• In 3D cultures, the Sox9-overexpressing chondrocytes secreted significantly higher levels of extracellular matrix polysaccharide glycosaminoglycan. It also upregulated the production of collagen II and Aggrecan mRNA in both expression systems, with similar patterns observed with immunohistochemical staining.

Conclusion

• The research concluded that immortalization of equine chondrocytes allows for stable proliferation, but reduces the potential for chondrogenic differentiation.
• However, by modulating the expression of Sox9, researchers were able to control the hypertrophic characteristics of the immortalized cells.